Pls take your time to give a look at the ROCK II LBCT presentation, during latest EuroPCR, within the intravascular imaging LBCT session!
from minute 42
https://virtualevent.pcronline.com/europcr-2019/videos/new-trials-in-coronary-imaging-and-physiology
ASTBOURNE
This is a just released review of our group, on the use of Stentys foro coronary use-Future Cardiology.
Stentys review
My interview at India Live 2019, on: OCT, DCB and BRS technologies-an update.
interviewer Dr Shadanand Shetty
I am proud to inform that FASICO NATIVES has been accepted for publication in the Journal of Cardiovascular Medicine.
After FASICO and NANOLUTE’ this is a crucial piece for the assessment of the safety and efficacy of Magic Touch sirolimus-eluting DCB. In this study, which will be available soon for the readers, we have conducted a core-lab assessment of the angiographic outcome of SCB for native coronary vessel disease.
With more than one third of patients showing late lumen enlargement (just like the top-in-class paclitaxel DCB), the average LLL was 0.09mm in this cohort of consecutive small-vessel-disease patients.
Core lab analysis was performed by Cardialysis (Rotterdam, NL).
…waiting for the interim analysis of the EASTBOURNE study, 1043 patients, to be presented at EuroPCR 2019 as late breaking clinical trial!
